SOURCE: BioMedReports

BiomedReports

April 04, 2011 12:19 ET

Trade Alerts Issued for TapImmune and Northwest Biotherapeutics

LOS ANGELES, CA--(Marketwire - April 4, 2011) - A Dual Trade Alert has been issued for both TapImmune Inc. (OTCBB: TPIV) and Northwest Biotherapeutics (OTCBB: NWBO) pending important clinical and financial developments for the firms whose drug candidates are attracting attention, according to biotech investing news portal BioMedReports.

The full report on both firms is now available at:

http://biomedreports.com/2011040465658/penny-biotechs-now-set-to-run.html

Investors interested in accessing BioMedReports' complete database of clinical trials and upcoming FDA decisions can go to:

http://biomedreports.com/access-our-exclusive-fda-and-clinical-trials-calendars.html

News developments and live healthcare sector updates are available constantly via twitter at: http://twitter.com/BioMedReports

About BioMedReports.Com

BioMedReports is a news portal covering the biomedical news and financial sector. BioMedReports is not paid or compensated to report the news and developments of publicly traded companies in the healthcare sector of the markets.

Full disclosures and information about the stocks are available at BioMedReports.Com

Contact Information

  • Media Contacts Only:

    Mary Davila
    Assistant Editor
    BioMedReports.Com
    e-mail: Email Contact
    Tel: +1 323 472 4480
    Fax: +1 888 210 3556